NMBDs questions Flashcards
Muscle Relaxants:
a. Baclofen is a GABA mimetic agent
a. True. Baclofen is a GABA agonist
b. Vecuronium is a nicotinic receptor antagonist
b. True, Vecuronium is a non-depolarizing NMBD. Non-depolarizing NMBDs competitively antagonize ACh at the postsynaptic nicotinic receptor
c. Rifampicin prolongs the muscle relaxant effects of vecuronium
c. False. Rifampicin induces cytochrome p450 enzymes, which metabolize vecuronium in the liver. Therefore, reducing the effect
d. Atropine inhibits acetylcholinesterase
d. False. Neostigmine inhibits ach-e. Atropine blocks muscarinic receptors
e. Vecuronium induces more histamine release than pancuronium
e. False. Most non-depolarizing NMBDs release histamine except rocuronium
Succinylcholine:
a. Is a non-depolarizing neuromuscular blocker
a. False. Succinylcholine is the only polarizing NMBD in use
Succinylcholine:
b. Has a faster onset of action than cis-atracurium
b. True. Fast acting
Succinylcholine:
c. Competes with mivacurium for plasma cholinesterase
c. True, Both are metabolized by plasma cholinestares
Succinylcholine:
d. Is used to treat malignant hyperthermia
d. F. Causes malignant hyperthermia
Succinylcholine:
e. Causes hypertension
e. False. Causes hypotension.
Neuromuscular Blocking agents
a. vecuronium antagonizes the effects of acetylcholine at the post synaptic nicotinic receptor
a. True. Non-depolarizing NMBDs competitively antagonize ACh at the postsynaptic nicotinic receptor
b. cis-atracurium is metabolized in the liver
b. False. Spontaneous (Hoffman) degradation. Drug of choice in liver failure
c. pancuronium has a longer duration of action than succinylcholine
c. True. Pancuronium is long lasting
d. vecuronium crosses the blood brain barrier
d. False ND-NMBD do not cross the BBB or placenta
e. succinylcholine reverses muscle rigidity in patients with malignant hyperthermia
e. False. Malignant hyperthermia is a consequence of succinylcholine
Muscle relaxants
a. dantrolene activates the calcium channel in the sarcoplasmic reticulum
a. False. Dantrolene inhibits the release of calcium
b. baclofen is an agonist at GABA-B receptors
b. True
Muscle relaxants
a. dantrolene activates the calcium channel in the sarcoplasmic reticulum
a. False. Dantrolene inhibits the release of calcium
.
b. baclofen is an agonist at GABA-B receptors
b. True
c. orphenadrine is contraindicated in glaucoma
c. True
d. diazepam enhances the effects of GABA in the spinal cord
d. False, diazepam is effective for spasticity of a cerebral origin. Baclofen is used for spinal
e. methocarbamol is indicated in the treatment of myasthenia gravis
e. False
Non-Depolarising neuromuscular blockers
a. include mivacurium
a. True. Mivacurium, atracurium, vecuronium, rocuronium, d-tubocurarine and pancuronium
Non-Depolarising neuromuscular blockers
b. are administered intravenously
b. True.
Non-Depolarising neuromuscular blockers
c. cause sedation
c. False. Cause hypotension and bronchospasm, Pancuronium causes tachycardia and elevated BP
Non-Depolarising neuromuscular blockers
d. are metabolised by acetylcholinesterases
d. False, deplorizing NMBDs
Non-Depolarising neuromuscular blockers
e. have a faster onset of action than depolarising neuromuscular blockers
e. False.
Depolarising neuromuscular blockers
a. include mivacurium
a. False, Succinylcholine
Depolarising neuromuscular blockers
b. are administered orally
b. False.
Depolarising neuromuscular blockers
c. have a faster onset than non-depolarising neuromuscular blockers
c. True
Depolarising neuromuscular blockers
d. are metabolised by acetylcholinesterases
d. True Metabolism: quickly hydrolyzed plasma pseudocholinesterases
Neuromuscular blocking agents
a. succinylcholine has a slower onset of action than vecuronium
a. False, depolarizing much quicker
b. neostigmine reverses the muscle relaxant effects of cis-atracurium
b. True.
c. vecuronium induces the release of more histamine than pancuronium
c. False, all have histamine except rocuronium
d. succinylcholine causes malignant hyperthermia as an adverse effect
d. True
e. morphine potentiates the respiratory depressant effects of vecuronium
e. False. Vecuronium doesn’t cause respiratory depression
Vecuronium
a. is metabolised by plasma cholinesterase
a. False. Liver
Vecuronium
b. has a longer duration of action than succinylcholine
b. True
Vecuronium
c. is less cardiotoxic than pancuronium
c. False.
Vecuronium
e. crosses the blood-brain barrier
e. False. Non-depolarizing NMBD do not cross the BBB